POLAND - Enterprise Investors take 50% stake in PBKM

The expansion deal was carried out from the investor's Enterprise Venture Fund I (EVF I), the venture capital fund.

A stem cell bank, PBKM is the largest such facility in Poland and the fourth largest cord blood bank in Europe. The company was established in 2002 and operates in Poland and, through subsidiaries and related companies in Hungary, Romania, Latvia, Italy and Spain.

Stored umbilical cord blood stem cells can be used to treat more than 70 diseases, including leukemias, certain types of cancer, and immune system disorders.

The company's revenues and profits have grown at an average annual rate exceeding 30% in the last few years. Together with its subsidiaries, the company achieved total sales of almost PLN 20m (nearly EUR 5m) in 2008. Sales are expected to grow by 30% in 2009.

PBKM is Enterprise Venture Fund's fifth investment in the last 11 months.

• Tweet  
• Facebook  
• LinkedIn  
• Google plus  
• Send to  

• Topics
• Expansion
• CEE